Healthcare perspectives from The Economist Intelligence Unit

Color

#DB444B

Hero Carousel

Spotlight

Bringing healthcare to hard-hit areas in Bangladesh

YouTube

https://www.youtube.com/channel/UCQDMOSbJtqrtNzif5rS22OQ

Slideshare

http://www.slideshare.net/economistintelligenceunit

Pinterest

https://www.pinterest.com/theeiu/

Feeling the flu strain

10 things to hate about flu — taken from our recent report on corporate strategies for battling the virus

Strategies for seasonal influenza

Report Summary

Strategies for seasonal influenza: spreading prevention across the workforce is an Economist Intelligence Unit report, sponsored by Novartis. It analyses changing corporate perceptions in the US and western Europe about the impact of seasonal influenza and the prevention measures companies are putting in place.

Tackling the rise of chronic disease in North Africa

A newly released report from the World Bank and the Institute for Health Metrics and Evaluation (IHME) presents clear evidence of the speed and extent of the rise of chronic disease across the Middle East and North Africa.

Frugal innovation in healthcare

The Aravind Eye Care System aims to deliver high-quality, low-cost ophthalmological care to some of India’s poorest people. In 2012, it conducted over 370,000 eye operations including laser procedures – 55% of them delivered at low or no cost. Mr Thulasiraj, Executive Director at Aravind, explains how the system works.

Understanding value in health and healthcare

I look forward to meeting many of you at The Economist's Healthy Europe conference in Zurich next week.

Measuring the cost of cybercrime

In this two-part series, sponsored by Booz Allen Hamilton, the EIU examines just how well we understand the "hard" and "soft" costs that cyberattacks inflict on companies.

And the healthiest country in Europe is….

I'll be in Zurich next month for The Economist's Healthy Europe conference, where we'll get to grips with a tough question: how, in a context of financial crisis, to reform Europe's healthcare systems to cope with an ageing population and the rising burden of chronic (physical and mental) disease.

Health care reform and life sciences

In the past, the life sciences industry has been focused on developing the next blockbuster drug, or expanding to markets that can offer considerable growth. But now, companies also have to contend with a wave of dramatic changes in many markets. Countries like the United States, China, Brazil, Germany, France and the United Kingdom have recently passed substantial health care legislation that will have a significant impact on the life sciences industry.

Tomorrow’s pharma

In a healthcare world that’s focussed on outcomes rather than treatments, innovation is whatever can help achieve those outcomes cost-effectively.

Bringing it all together

Hepatitis C may be the serious disease that most combines widespread prevalence with widespread ignorance. According to the WHO, it kills 350,000 people per year, and 150 million have the chronic form of the hepatitis C virus (HCV). Yet, HCV is entirely preventable and largely curable.

Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week